Two Sigma Advisers LP Purchases 8,363 Shares of Relx Plc (NYSE:RELX)

Two Sigma Advisers LP grew its stake in shares of Relx Plc (NYSE:RELX - Free Report) by 13.9% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 68,463 shares of the technology company's stock after purchasing an additional 8,363 shares during the period. Two Sigma Advisers LP's holdings in Relx were worth $3,110,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in RELX. CENTRAL TRUST Co increased its holdings in Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock worth $26,000 after purchasing an additional 529 shares in the last quarter. Transce3nd LLC bought a new stake in Relx during the 4th quarter worth approximately $40,000. Sierra Ocean LLC bought a new stake in Relx during the 4th quarter worth approximately $43,000. Brown Brothers Harriman & Co. increased its holdings in Relx by 218.5% during the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares in the last quarter. Finally, Private Trust Co. NA increased its holdings in Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after purchasing an additional 199 shares in the last quarter. 15.02% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

RELX has been the subject of several recent analyst reports. Wall Street Zen lowered Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. The Goldman Sachs Group initiated coverage on Relx in a report on Wednesday, March 26th. They issued a "buy" rating for the company. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. Finally, Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Relx has a consensus rating of "Buy".

Relx Stock Performance

NYSE RELX traded down $1.18 on Thursday, hitting $53.87. 1,096,618 shares of the stock traded hands, compared to its average volume of 717,114. The business's fifty day moving average is $52.13 and its two-hundred day moving average is $49.33. Relx Plc has a 12 month low of $43.28 and a 12 month high of $56.33. The firm has a market capitalization of $99.44 billion, a price-to-earnings ratio of 28.96, a PEG ratio of 2.73 and a beta of 0.86. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.